Multiple genes encoding mitochondrial ribosomes are downregulated in brain and blood samples of individuals with schizophrenia

References

• Ahmad T, Aggarwal K, Pattnaik B, Mukherjee S, Sethi T, Tiwari BK, Kumar M, Micheal A, Mabalirajan U, Ghosh B, et al. 2013. Computational classification of mitochondrial shapes reflects stress and redox state. Cell Death Dis. 4(1):e461–e461.
   Google Scholar
• Altar CA, Jurata LW, Charles V, Lemire A, Liu P, Bukhman Y, Young TA, Bullard J, Yokoe H, Webster MJ, et al. 2005. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry. 58(2):85–96.
   PubMed Web of Science ®Google Scholar
• Amato D, Canneva F, Cumming P, Maschauer S, Groos D, Dahlmanns JK, Grömer TW, Chiofalo L, Dahlmanns M, Zheng F, et al. 2020. A dopaminergic mechanism of antipsychotic drug efficacy, failure, and failure reversal: the role of the dopamine transporter. Mol Psychiatry. 25(9):2101–2118.
   PubMed Web of Science ®Google Scholar
• Andreasen NC, Pierson R. 2008. The role of the cerebellum in schizophrenia. Biol Psychiatry. 64(2):81–88.
   PubMed Web of Science ®Google Scholar
• Barnes MR, Huxley-Jones J, Maycox PR, Lennon M, Thornber A, Kelly F, Bates S, Taylor A, Reid J, Jones N, et al. 2011. Transcription and pathway analysis of the superior temporal cortex and anterior prefrontal cortex in schizophrenia. J Neurosci Res. 89(8):1218–1227.
   PubMed Web of Science ®Google Scholar
• Bergman O, Ben-Shachar D. 2016. Mitochondrial oxidative phosphorylation system (OXPHOS) deficits in schizophrenia. Can J Psychiatry. 61(8):457–469.
   PubMed Web of Science ®Google Scholar
• van Beveren NJM, Buitendijk GHS, Swagemakers S, Krab LC, Röder C, de Haan L, van der Spek P, Elgersma Y. 2012. Marked reduction of AKT1 expression and deregulation of AKT1-associated pathways in peripheral blood mononuclear cells of schizophrenia patients. PLoS One. 7(2):e32618.
   PubMed Web of Science ®Google Scholar
• Birdsill AC, Walker DG, Lue L, Sue LI, Beach TG. 2011. Postmortem interval effect on RNA and gene expression in human brain tissue. Cell Tissue Bank. 12(4):311–318.
   PubMed Web of Science ®Google Scholar
• Bousman CA, Chana G, Glatt SJ, Chandler SD, Lucero GR, Tatro E, May T, Lohr JB, Kremen WS, Tsuang MT, et al. 2010. Preliminary evidence of ubiquitin proteasome system dysregulation in schizophrenia and bipolar disorder: convergent pathway analysis findings from two independent samples. Am J Med Genet. 153B(2):494–502.
   PubMed Web of Science ®Google Scholar
• Chang DTW, Reynolds IJ. 2006. Mitochondrial trafficking and morphology in healthy and injured neurons. Prog Neurobiol. 80(5):241–268.
   PubMed Web of Science ®Google Scholar
• Chen C, Cheng L, Grennan K, Pibiri F, Zhang C, Badner JA, Kelsoe JR, Greenwood TA, Nievergelt CM, Barrett TB, et al. 2013. Two gene co-expression modules differentiate psychotics and controls. Mol Psychiatry. 18(12):1308–1314.
   PubMed Web of Science ®Google Scholar
• Chieffi S, Ilardi CR, Iavarone A. 2018. Parietal lobe dysfunction in schizophrenia: a review. CPSR. 14(2):71–83.
   Google Scholar
• De Silva D, Tu Y-T, Amunts A, Fontanesi F, Barrientos A. 2015. Mitochondrial ribosome assembly in health and disease. Cell Cycle. 14(14):2226–2250.
   PubMed Web of Science ®Google Scholar
• Fleiss JL. 1993. The statistical basis of meta-analysis. Stat Methods Med Res. 2(2):121–145.
   PubMedGoogle Scholar
• Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, Gormley P, Georgieva L, Rees E, Palta P, Ruderfer DM, et al. 2014. De novo mutations in schizophrenia implicate synaptic networks. Nature. 506(7487):179–184.
   PubMed Web of Science ®Google Scholar
• Glausier JR, Enwright JF, Lewis DA. 2020. Diagnosis- and cell type-specific mitochondrial functional pathway signatures in schizophrenia and bipolar disorder. Am J Psychiatry. 177(12):1140–1150.
   PubMed Web of Science ®Google Scholar
• Goldstein KE, Hazlett EA, New AS, Haznedar MM, Newmark RE, Zelmanova Y, Passarelli V, Weinstein SR, Canfield EL, Meyerson DA, et al. 2009. Smaller superior temporal gyrus volume specificity in schizotypal personality disorder. Schizophr Res. 112(1-3):14–23.
   PubMed Web of Science ®Google Scholar
• Gopisetty G, Thangarajan R. 2016. Mammalian mitochondrial ribosomal small subunit (MRPS) genes: a putative role in human disease. Gene. 589(1):27–35.
   PubMed Web of Science ®Google Scholar
• Hahn B, Robinson BM, Leonard CJ, Luck SJ, Gold JM. 2018. Posterior parietal cortex dysfunction is central to working memory storage and broad cognitive deficits in schizophrenia. J Neurosci. 38(39):8378–8387.
   PubMed Web of Science ®Google Scholar
• Hedges LV. 1981. Distribution theory for glass’s estimator of effect size and related estimators. J Educ Stat. 6(2):107–128.
   Google Scholar
• Hjelm BE, Rollins B, Mamdani F, Lauterborn JC, Kirov G, Lynch G, Gall CM, Sequeira A, Vawter MP. 2015. Evidence of mitochondrial dysfunction within the complex genetic etiology of schizophrenia. Mol Neuropsychiatry. 1(4):201–219.
   PubMedGoogle Scholar
• Hüttemann M, Lee I, Pecinova A, Pecina P, Przyklenk K, Doan JW. 2008. Regulation of oxidative phosphorylation, the mitochondrial membrane potential, and their role in human disease. J Bioenerg Biomembr. 40(5):445–456.
   PubMed Web of Science ®Google Scholar
• Iwamoto K, Kakiuchi C, Bundo M, Ikeda K, Kato T. 2004. Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry. 9(4):406–416.
   PubMed Web of Science ®Google Scholar
• Jones DC, Gunasekar PG, Borowitz JL, Isom GE. 2000. Dopamine-induced apoptosis is mediated by oxidative stress and is enhanced by cyanide in differentiated PC12 cells. J Neurochem. 74(6):2296–2304.
   PubMed Web of Science ®Google Scholar
• Jongsma HE, Turner C, Kirkbride JB, Jones PB. 2019. International incidence of psychotic disorders, 2002-17: a systematic review and meta-analysis. Lancet Public Health. 4(5):e229–e244.
   PubMed Web of Science ®Google Scholar
• Katz Shroitman N, Yitzhaky A, Ben Shachar D, Gurwitz D, Hertzberg L. 2023. Meta-analysis of brain samples of individuals with schizophrenia detects down-regulation of multiple ATP synthase encoding genes in both females and males. J Psychiatr Res. 158:350–359.
   PubMed Web of Science ®Google Scholar
• Khadimallah I, Jenni R, Cabungcal J-H, Cleusix M, Fournier M, Beard E, Klauser P, Knebel J-F, Murray MM, Retsa C, et al. 2022. Mitochondrial, exosomal miR137-COX6A2 and gamma synchrony as biomarkers of parvalbumin interneurons, psychopathology, and neurocognition in schizophrenia. Mol Psychiatry. 27(2):1192–1204.
   PubMed Web of Science ®Google Scholar
• Kung L, Roberts RC. 1999. Mitochondrial pathology in human schizophrenic striatum: a postmortem ultrastructural study. Synapse. 31(1):67–75.
   PubMed Web of Science ®Google Scholar
• Kunii Y, Yabe H, Wada A, Yang Q, Nishiura K, Niwa S-I. 2011. Altered DARPP-32 expression in the superior temporal gyrus in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 35(4):1139–1143.
   PubMed Web of Science ®Google Scholar
• Lanz TA, Reinhart V, Sheehan MJ, Rizzo SJS, Bove SE, James LC, Volfson D, Lewis DA, Kleiman RJ. 2019. Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder. Transl Psychiatry. 9(1):1–13.
   PubMedGoogle Scholar
• Li Z, Okamoto K-I, Hayashi Y, Sheng M. 2004. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell. 119(6):873–887.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D. 2009. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 62(10):e1–e34.
   PubMed Web of Science ®Google Scholar
• Maurer I, Zierz S, Möller H-J. 2001. Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia. Schizophr Res. 48(1):125–136.
   PubMed Web of Science ®Google Scholar
• Maycox PR, Kelly F, Taylor A, Bates S, Reid J, Logendra R, Barnes MR, Larminie C, Jones N, Lennon M, et al. 2009. Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function. Mol Psychiatry. 14(12):1083–1094.
   PubMed Web of Science ®Google Scholar
• Miller KE, Sheetz MP. 2004. Axonal mitochondrial transport and potential are correlated. J Cell Sci. 117(Pt 13):2791–2804.
   PubMed Web of Science ®Google Scholar
• Mulcrone J, Whatley SA, Ferrier IN, Marchbanks RM. 1995. A study of altered gene expression in frontal cortex from schizophrenic patients using differential screening. Schizophr Res. 14(3):203–213.
   PubMed Web of Science ®Google Scholar
• Ni P, Chung S. 2020. Mitochondrial dysfunction in schizophrenia. BioEssays. 42(6):1900202.
   Web of Science ®Google Scholar
• Orlov ND, Giampietro V, O’Daly O, Lam S-L, Barker GJ, Rubia K, McGuire P, Shergill SS, Allen P. 2018. Real-time fMRI neurofeedback to down-regulate superior temporal gyrus activity in patients with schizophrenia and auditory hallucinations: a proof-of-concept study. Transl Psychiatry. 8(1):1–10.
   PubMedGoogle Scholar
• Owen MJ. 2023. Genomic insights into schizophrenia. R Soc Open Sci. 10(2):230125.
   PubMed Web of Science ®Google Scholar
• Park H-J, Choi I, Leem K-H. 2021. Decreased brain pH and pathophysiology in schizophrenia. IJMS. 22(16):8358.
   Google Scholar
• Paz RD, Andreasen NC, Daoud SZ, Conley R, Roberts R, Bustillo J, Perrone-Bizzozero NI. 2006. Increased expression of activity-dependent genes in cerebellar glutamatergic neurons of patients with schizophrenia. Am J Psychiatry. 163(10):1829–1831.
   PubMed Web of Science ®Google Scholar
• Pietersen CY, Mauney SA, Kim SS, Lim MP, Rooney RJ, Goldstein JM, Petryshen TL, Seidman LJ, Shenton ME, McCarley RW, et al. 2014. Molecular profiles of pyramidal neurons in the superior temporal cortex in schizophrenia. J Neurogenet. 28(1-2):53–69.
   PubMed Web of Science ®Google Scholar
• Pietersen CY, Mauney SA, Kim SS, Passeri E, Lim MP, Rooney RJ, Goldstein JM, Petreyshen TL, Seidman LJ, Shenton ME, et al. 2014. Molecular profiles of parvalbumin-immunoreactive neurons in the superior temporal cortex in schizophrenia. J Neurogenet. 28(1–2):70–85.
   PubMed Web of Science ®Google Scholar
• Pomarol-Clotet E, Canales-Rodríguez EJ, Salvador R, Sarró S, Gomar JJ, Vila F, Ortiz-Gil J, Iturria-Medina Y, Capdevila A, McKenna PJ. 2010. Medial prefrontal cortex pathology in schizophrenia as revealed by convergent findings from multimodal imaging. Mol Psychiatry. 15(8):823–830.
   PubMed Web of Science ®Google Scholar
• Pope PT, Webster JT. 1972. The use of an F-statistic in stepwise regression procedures. Technometrics. 14(2):327–340.
   Web of Science ®Google Scholar
• Prince JA, Blennow K, Gottfries CG, Karlsson I, Oreland L. 1999. Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics. Neuropsychopharmacology. 21(3):372–379.
   PubMed Web of Science ®Google Scholar
• Prince JA, Harro J, Blennow K, Gottfries CG, Oreland L. 2000. Putamen mitochondrial energy metabolism is highly correlated to emotional and intellectual impairment in schizophrenics. Neuropsychopharmacology. 22(3):284–292.
   PubMed Web of Science ®Google Scholar
• Rizvi S, Khan AM, Saeed H, Aribara AM, Carrington A, Griffiths A, Mohit A. 2018. Schizophrenia in DiGeorge syndrome: a unique case report. Cureus. 10(8):e3142.
   PubMed Web of Science ®Google Scholar
• Roberts RC. 2021. Mitochondrial dysfunction in schizophrenia: with a focus on postmortem studies. Mitochondrion. 56:91–101.
   PubMed Web of Science ®Google Scholar
• Schwarzer G. 2007. Meta: An R package for meta-analysis. R News. 7(3):40–45.
   Google Scholar
• Segev S, Yitzhaky A, Ben Shachar D, Hertzberg L. 2023. VDAC genes down-regulation in brain samples of individuals with schizophrenia is revealed by a systematic meta-analysis. Neurosci Res. https://doi.org/10.1016/j.neures.2023.01.012
   PubMed Web of Science ®Google Scholar
• Sekiguchi H, Pavey G, Dean B. 2019. Altered levels of dopamine transporter in the frontal pole and dorsal striatum in schizophrenia. NPJ Schizophr. 5(1):20.
   PubMedGoogle Scholar
• Sheng Z-H, Cai Q. 2012. Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration. Nat Rev Neurosci. 13(2):77–93.
   PubMed Web of Science ®Google Scholar
• Simpson EH, Kellendonk C, Kandel E. 2010. A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia. Neuron. 65(5):585–596.
   PubMed Web of Science ®Google Scholar
• Smoller JW, Andreassen OA, Edenberg HJ, Faraone SV, Glatt SJ, Kendler KS. 2019. Psychiatric genetics and the structure of psychopathology. Mol Psychiatry. 24(3):409–420.
   PubMed Web of Science ®Google Scholar
• Sorg C, Manoliu A, Neufang S, Myers N, Peters H, Schwerthöffer D, Scherr M, Mühlau M, Zimmer C, Drzezga A, et al. 2013. Increased intrinsic brain activity in the striatum reflects symptom dimensions in schizophrenia. Schizophr Bull. 39(2):387–395.
   PubMed Web of Science ®Google Scholar
• Szabadkai G, Duchen MR. 2008. Mitochondria: the hub of cellular Ca2+ signaling. Physiology (Bethesda). 23(2):84–94.
   PubMed Web of Science ®Google Scholar
• Szatkiewicz JP, O’Dushlaine C, Chen G, Chambert K, Moran JL, Neale BM, Fromer M, Ruderfer D, Akterin S, Bergen SE, et al. 2014. Copy number variation in schizophrenia in Sweden. Mol Psychiatry. 19(7):762–773.
   PubMed Web of Science ®Google Scholar
• Trubetskoy V, Pardiñas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, Bryois J, Chen C-Y, Dennison CA, Hall LS, et al. 2022. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 604(7906):502–508.
   PubMed Web of Science ®Google Scholar
• Uranova N, Orlovskaya D, Vikhreva O, Zimina I, Kolomeets N, Vostrikov V, Rachmanova V. 2001. Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull. 55(5):597–610.
   PubMed Web of Science ®Google Scholar
• Uranova NA, Vikhreva OV, Rakhmanova VI. 2021. Abnormal microglial reactivity in gray matter of the prefrontal cortex in schizophrenia. Asian J Psychiatr. 63:102752.
   PubMed Web of Science ®Google Scholar
• Washizuka S, Iwamoto K, Kakiuchi C, Bundo M, Kato T. 2009. Expression of mitochondrial complex I subunit gene NDUFV2 in the lymphoblastoid cells derived from patients with bipolar disorder and schizophrenia. Neurosci Res. 63(3):199–204.
   PubMed Web of Science ®Google Scholar
• Whatley SA, Curti D, Marchbanks RM. 1996. Mitochondrial involvement in schizophrenia and other functional psychoses. Neurochem Res. 21(9):995–1004.
   PubMed Web of Science ®Google Scholar
• Xu H, Yang F. 2022. The interplay of dopamine metabolism abnormalities and mitochondrial defects in the pathogenesis of schizophrenia. Transl Psychiatry. 12(1):464.
   PubMed Web of Science ®Google Scholar
• Xu H, Yang H-J, McConomy B, Browning R, Li X-M. 2010. Behavioral and neurobiological changes in C57BL/6 mouse exposed to cuprizone: effects of antipsychotics. Front Behav Neurosci. 4:8.
   PubMed Web of Science ®Google Scholar
• Yeganeh-Doost P, Gruber O, Falkai P, Schmitt A. 2011. The role of the cerebellum in schizophrenia: from cognition to molecular pathways. Clinics. 66(Suppl 1):71–77.
   PubMedGoogle Scholar
• Youle RJ, van der Bliek AM. 2012. Mitochondrial fission, fusion, and stress. Science. 337(6098):1062–1065.
   PubMed Web of Science ®Google Scholar
• Zhou S-Y, Suzuki M, Takahashi T, Hagino H, Kawasaki Y, Matsui M, Seto H, Kurachi M. 2007. Parietal lobe volume deficits in schizophrenia spectrum disorders. Schizophr Res. 89(1–3):35–48.
   PubMed Web of Science ®Google Scholar